These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2226524)

  • 1. Transfer of lipoproteins from plasma to the cell populations of the normal and atherosclerotic arterial tissue.
    Bondjers G; Wiklund O; Fager G; Camejo EH; Camejo G
    Eur Heart J; 1990 Aug; 11 Suppl E():158-63. PubMed ID: 2226524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteoglycans, lipoproteins, and atherosclerosis.
    Srinivasan SR; Radhakrishnamurthy B; Vijayagopal P; Berenson GS
    Adv Exp Med Biol; 1991; 285():373-81. PubMed ID: 1858569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial uptake and synthesis of low density lipoproteins.
    Hollander W; Paddock J; Colombo MA
    Prog Biochem Pharmacol; 1977; 13():123-33. PubMed ID: 200954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of low density lipoprotein association with the arterial intima. A possible environment for the antiatherogenic action of beta-blockers.
    Camejo G; Hurt E; Thubrikar M; Bondjers G
    Circulation; 1991 Dec; 84(6 Suppl):VI17-22. PubMed ID: 1683606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.
    Hurt-Camejo E; Camejo G; Rosengren B; López F; Ahlström C; Fager G; Bondjers G
    Arterioscler Thromb; 1992 May; 12(5):569-83. PubMed ID: 1576119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more.
    Pentikäinen MO; Oksjoki R; Oörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):211-7. PubMed ID: 11834518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial metabolism of lipoproteins in relation to atherogenesis.
    Steinberg D
    Ann N Y Acad Sci; 1990; 598():125-35. PubMed ID: 2248432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
    Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
    J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties.
    Chang MY; Potter-Perigo S; Tsoi C; Chait A; Wight TN
    J Biol Chem; 2000 Feb; 275(7):4766-73. PubMed ID: 10671509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.
    Camejo G; Hurt-Camejo E; Wiklund O; Bondjers G
    Atherosclerosis; 1998 Aug; 139(2):205-22. PubMed ID: 9712326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
    Kovanen PT
    Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a proteoglycan variant from human aorta exhibiting a marked affinity for low density lipoprotein and demonstration of its enhanced expression in atherosclerotic plaques.
    Vijayagopal P; Figueroa JE; Fontenot JD; Glancy DL
    Atherosclerosis; 1996 Dec; 127(2):195-203. PubMed ID: 9125309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake and degradation of low density lipoproteins in atherosclerotic rabbit aorta: role of local LDL modification.
    Wiklund O; Mattsson L; Björnheden T; Camejo G; Bondjers G
    J Lipid Res; 1991 Jan; 32(1):55-62. PubMed ID: 2010694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of heparin-treated low density lipoprotein by peroxidases.
    Upritchard JE; Sutherland WH
    Atherosclerosis; 1999 Oct; 146(2):211-9. PubMed ID: 10532677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis.
    Nielsen LB
    Atherosclerosis; 1996 Jun; 123(1-2):1-15. PubMed ID: 8782833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monocyte-derived macrophages bind low-density-lipoprotein-proteoglycan complexes by a receptor different from the low-density-lipoprotein receptor.
    Vijayagopal P; Srinivasan SR; Radhakrishnamurthy B; Berenson GS
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):837-44. PubMed ID: 8382053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors modulating the interaction of LDL with an arterial lipoprotein complexing proteoglycan: the effect of HDL.
    Camejo G; Cortez MM; López F; Starosta R; Mosquera B; Socorro L
    Acta Med Scand Suppl; 1980; 642():159-64. PubMed ID: 6935941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.